Michigan HB4878 regulates the federal 340B drug pricing program, requiring reporting and prohibiting certain conduct related to drugs and the program.
Michigan HB4878 establishes regulations for the federal 340B drug pricing program, which provides discounts on covered outpatient drugs to certain entities. The bill mandates that manufacturers report information on prescription drugs with significant cost increases to the Department of Licensing and Regulatory Affairs. Hospitals participating in the 340B program must report on their community investments and drug acquisition costs.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.